Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Boeri

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 5, 2017
Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancerUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.
Journal of the National Cancer Institute|March 22, 2014
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]Federica Polato, Paolo Rusconi, Stefano Zangrossi, et al.
Frontiers in Oncology|August 5, 2022
A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung CancerChiara Gargiuli, Loris De Cecco, Andrea Mariancini, et al.
Oncotarget|November 1, 2019
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Oncotarget|October 10, 2015
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Annals of Surgical Oncology|January 5, 2019
Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung MetastasectomyUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2017
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung CancersCarla Verri, Cristina Borzi, Todd Holscher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2026
Clinical Value of Combining Molecular and Immune Blood Tests to Safely Reduce False Positives in Low-Dose CT Lung Cancer ScreeningAnna Zanghì, Massimo Moro, Orazio Fortunato, et al.
Oncotarget|May 10, 2014
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypesErica Lorenzetto, Monica Brenca, Mattia Boeri, et al.
Cancer Gene Therapy|February 8, 2024
Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsyMattia Boeri, Stefano Signoroni, Chiara Maura Ciniselli, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|May 5, 2017
Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancerUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.
Journal of the National Cancer Institute|March 22, 2014
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]Federica Polato, Paolo Rusconi, Stefano Zangrossi, et al.
Frontiers in Oncology|August 5, 2022
A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung CancerChiara Gargiuli, Loris De Cecco, Andrea Mariancini, et al.
Oncotarget|November 1, 2019
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Oncotarget|October 10, 2015
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Annals of Surgical Oncology|January 5, 2019
Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung MetastasectomyUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2017
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung CancersCarla Verri, Cristina Borzi, Todd Holscher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2026
Clinical Value of Combining Molecular and Immune Blood Tests to Safely Reduce False Positives in Low-Dose CT Lung Cancer ScreeningAnna Zanghì, Massimo Moro, Orazio Fortunato, et al.
Oncotarget|May 10, 2014
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypesErica Lorenzetto, Monica Brenca, Mattia Boeri, et al.
Cancer Gene Therapy|February 8, 2024
Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsyMattia Boeri, Stefano Signoroni, Chiara Maura Ciniselli, et al.
Pageof 6